Pricing Log in Create free account
Saturday 17 October 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cencora, Inc. (COR) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Cencora, Inc. (COR) trades at a P/B ratio of 20.3×. Over the past ten years it has ranged from 0.0× (June 2021) to 509× (December 2022); the current reading is higher than 58% of that period. That is above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 34.7× (38.95%)
FY2024 56.8× 4.34%
FY2023 54.4× (86.25%)
FY2022 396× 840.49%
FY2021 42.1× —
FY2020 0.0× —
FY2019 5.8× (12.79%)
FY2018 6.6× (24.77%)
FY2017 8.8× 9.46%
FY2016 8.1× (76.01%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 16.9× (1.02%)
Mar 2026 17.0× (45.53%)
Dec 2025 31.3× (9.73%)
Sep 2025 34.7× 31.84%
42 more quarters

Against its own ten years

Low 0.0× High 509×
Ten-year median 13.9×
Current reading's percentile 53

P/B ratio against peers

Company P/B ratio
CAH Cardinal Health, Inc. compare n/m
HKPD Cellyan Biotechnology Co., Ltd compare n/m
ACH Accendra Health, Inc. compare n/m
MCK McKesson Corporation compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare 0.1×
COSM Cosmos Health Inc. compare 1.0×
HSIC Henry Schein, Inc. compare 2.6×
COR Cencora, Inc. 20.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on COR